Wockhardt FDA

Business

Wockhardt’s new antibiotic WCK 6777 gains FDA fast track status, completes phase I trial, stocks decline

whatnews.in - October 7, 2024

Wockhardt Limited announced today that its novel antibiotic WCK 6777 (Ertapenem/Zidebactam) has been granted Fast Track designation by the USFDA for treating complicated...

Latest news

Tesla, Rivian shares fall on report US President-elect Donald Trump plans to end EV tax credit

November 15, 2024

New Sri Lankan President’s Party Headed For Big Win In Snap Elections

November 15, 2024

Stock market holiday: NSE, BSE to remain closed today for Guru Nanak Jayanti

November 15, 2024

SBI raises MCLR across three tenors by 5 bps, effective November 15

November 15, 2024

Robert F Kennedy Jr, Vaccine Skeptic, To Head US Health Department

November 15, 2024

- Advertisement -

Wockhardt FDA

Wockhardt’s new antibiotic WCK 6777 gains FDA fast track status, completes phase I trial, stocks decline

Latest news

Tesla, Rivian shares fall on report US President-elect Donald Trump plans to end EV tax credit

New Sri Lankan President’s Party Headed For Big Win In Snap Elections

Stock market holiday: NSE, BSE to remain closed today for Guru Nanak Jayanti

SBI raises MCLR across three tenors by 5 bps, effective November 15

Robert F Kennedy Jr, Vaccine Skeptic, To Head US Health Department

About Us